Press release

Tracer merger: issues statement

The Competition and Markets Authority has published an issues statement as part of its inquiry into the completed acquisition by Alliance Medical Group Limited of the assets of IBA Molecular UK Limited used to produce Fluorodeoxyglucose 18F.